Literature DB >> 22778335

In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment.

Jacob Bor1, Frank Tanser, Marie-Louise Newell, Till Bärnighausen.   

Abstract

Antiretroviral therapy for HIV may have important economic benefits for patients and their households. We quantified the impact of HIV treatment on employment status among HIV patients in rural South Africa who were enrolled in a public-sector HIV treatment program supported by the President's Emergency Plan for AIDS Relief. We linked clinical data from more than 2,000 patients in the treatment program with ten years of longitudinal socioeconomic data from a complete community-based population cohort of more than 30,000 adults residing in the clinical catchment area. We estimated the employment effects of HIV treatment in fixed-effects regressions. Four years after the initiation of antiretroviral therapy, employment among HIV patients had recovered to about 90 percent of baseline rates observed in the same patients three to five years before they started treatment. Many patients initiated treatment early enough that they were able to avoid any loss of employment due to HIV. These results represent the first estimates of employment recovery among HIV patients in a general population, relative to the employment levels that these patients had prior to job-threatening HIV illness and the decision to seek care. There are large economic benefits to HIV treatment. For some patients, further gains could be obtained from initiating antiretroviral therapy earlier, prior to HIV-related job loss.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22778335      PMCID: PMC3819460          DOI: 10.1377/hlthaff.2012.0407

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  19 in total

1.  The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries.

Authors:  Katherine Leach-Kemon; David P Chou; Matthew T Schneider; Annette Tardif; Joseph L Dieleman; Benjamin P C Brooks; Michael Hanlon; Christopher J L Murray
Journal:  Health Aff (Millwood)       Date:  2011-12-14       Impact factor: 6.301

2.  Interim proposal for a WHO Staging System for HIV infection and Disease.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1990-07-20

Review 3.  Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence.

Authors:  Till Bärnighausen; Frank Tanser; François Dabis; Marie-Louise Newell
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

4.  The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya.

Authors:  Harsha Thirumurthy; Joshua Graff Zivin; Markus Goldstein
Journal:  J Hum Resour       Date:  2008

Review 5.  Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review.

Authors:  Jennifer Beard; Frank Feeley; Sydney Rosen
Journal:  AIDS Care       Date:  2009-11

6.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

7.  CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

Authors:  Jason V Baker; Grace Peng; Joshua Rapkin; Donald I Abrams; Michael J Silverberg; Rodger D MacArthur; Winston P Cavert; W Keith Henry; James D Neaton
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

8.  Economic returns to investment in AIDS treatment in low and middle income countries.

Authors:  Stephen Resch; Eline Korenromp; John Stover; Matthew Blakley; Carleigh Krubiner; Kira Thorien; Robert Hecht; Rifat Atun
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

9.  Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey.

Authors:  Frank Tanser; Victoria Hosegood; Till Bärnighausen; Kobus Herbst; Makandwe Nyirenda; William Muhwava; Colin Newell; Johannes Viljoen; Tinofa Mutevedzi; Marie-Louise Newell
Journal:  Int J Epidemiol       Date:  2007-11-12       Impact factor: 7.196

Review 10.  Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.

Authors:  Adamson S Muula; Thabale J Ngulube; Seter Siziya; Cecilia M Makupe; Eric Umar; Hans Walter Prozesky; Charles S Wiysonge; Ronald H Mataya
Journal:  BMC Public Health       Date:  2007-04-25       Impact factor: 3.295

View more
  55 in total

Review 1.  Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies.

Authors:  Kobus Herbst; Matthew Law; Pascal Geldsetzer; Frank Tanser; Guy Harling; Till Bärnighausen
Journal:  Curr Opin HIV AIDS       Date:  2015-11       Impact factor: 4.283

2.  Prospective cohort study of the impact of antiretroviral therapy on employment outcomes among HIV clients in Uganda.

Authors:  Sebastian Linnemayr; Peter Glick; Cissy Kityo; Peter Mugyeni; Glenn Wagner
Journal:  AIDS Patient Care STDS       Date:  2013-12       Impact factor: 5.078

3.  CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda.

Authors:  Atheendar S Venkataramani; Harsha Thirumurthy; Jessica E Haberer; Yap Boum Ii; Mark J Siedner; Annet Kembabazi; Peter W Hunt; Jeffrey N Martin; David R Bangsberg; Alexander C Tsai
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

4.  Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment.

Authors:  Jacob Bor; Abraham J Herbst; Marie-Louise Newell; Till Bärnighausen
Journal:  Science       Date:  2013-02-22       Impact factor: 47.728

5.  The economic benefits of high CD4 counts among people living with HIV/AIDS in Zambia.

Authors:  Nyasha Tirivayi; John R Koethe
Journal:  J Public Health (Oxf)       Date:  2016-12-02       Impact factor: 2.341

6.  Does Economic Strengthening Improve Viral Suppression Among Adolescents Living with HIV? Results From a Cluster Randomized Trial in Uganda.

Authors:  Laura Gauer Bermudez; Fred M Ssewamala; Torsten B Neilands; Lily Lu; Larissa Jennings; Gertrude Nakigozi; Claude A Mellins; Mary McKay; Miriam Mukasa
Journal:  AIDS Behav       Date:  2018-11

7.  The ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa.

Authors:  Jennifer Manne-Goehler; Livia Montana; Francesc Xavier Gómez-Olivé; Julia Rohr; Guy Harling; Ryan G Wagner; Alisha Wade; Chodziwadziwa W Kabudula; Pascal Geldsetzer; Kathleen Kahn; Stephen Tollman; Lisa F Berkman; Till W Bärnighausen; Thomas A Gaziano
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

8.  Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda.

Authors:  Harsha Thirumurthy; Gabriel Chamie; Vivek Jain; Jane Kabami; Dalsone Kwarisiima; Tamara D Clark; Elvin Geng; Maya L Petersen; Edwin D Charlebois; Moses R Kamya; Diane V Havlir
Journal:  AIDS       Date:  2013-02-20       Impact factor: 4.177

9.  Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania.

Authors:  Sandra I McCoy; Prosper F Njau; Carolyn Fahey; Ntuli Kapologwe; Suneetha Kadiyala; Nicholas P Jewell; William H Dow; Nancy S Padian
Journal:  AIDS       Date:  2017-03-27       Impact factor: 4.177

10.  Economics of antiretroviral treatment vs. circumcision for HIV prevention.

Authors:  Till Bärnighausen; David E Bloom; Salal Humair
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.